What is a stock summary page? Click here for an overview.
Business Description
BenQ Medical Technology Corp
NAICS : 334510
SIC : 3842
ISIN : TW0004116009
Description
BenQ Medical Technology Corp is engaged in the manufacturing, assembly, maintenance, repair, and sales of professional medical equipment and consumables. Its products include surgical and gynecology tables, digital OR solutions, halogen and LED surgical lights, and medical imaging products, among others.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.63 | |||||
| Equity-to-Asset | 0.21 | |||||
| Debt-to-Equity | 1.7 | |||||
| Debt-to-EBITDA | 3.08 | |||||
| Interest Coverage | 9.74 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.89 | |||||
| Beneish M-Score | -2.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 48 | |||||
| 3-Year EBITDA Growth Rate | 54.6 | |||||
| 3-Year EPS without NRI Growth Rate | 51.2 | |||||
| 3-Year FCF Growth Rate | -19.2 | |||||
| 3-Year Book Growth Rate | 2.6 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.4 | |||||
| 9-Day RSI | 43.26 | |||||
| 14-Day RSI | 40.91 | |||||
| 3-1 Month Momentum % | 3.3 | |||||
| 6-1 Month Momentum % | -11.17 | |||||
| 12-1 Month Momentum % | -17.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.75 | |||||
| Quick Ratio | 1.31 | |||||
| Cash Ratio | 0.67 | |||||
| Days Inventory | 67.53 | |||||
| Days Sales Outstanding | 66.87 | |||||
| Days Payable | 60.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5 | |||||
| Dividend Payout Ratio | 0.85 | |||||
| 3-Year Dividend Growth Rate | 26 | |||||
| Forward Dividend Yield % | 5 | |||||
| 5-Year Yield-on-Cost % | 7.25 | |||||
| Shareholder Yield % | -22.23 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.38 | |||||
| Operating Margin % | 6.99 | |||||
| Net Margin % | 2.2 | |||||
| FCF Margin % | 0.98 | |||||
| ROE % | 9.67 | |||||
| ROA % | 2.16 | |||||
| ROIC % | 8.45 | |||||
| 3-Year ROIIC % | 10.7 | |||||
| ROC (Joel Greenblatt) % | 19.94 | |||||
| ROCE % | 10.88 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 17.59 | |||||
| PE Ratio without NRI | 17.56 | |||||
| Shiller PE Ratio | 17.55 | |||||
| Price-to-Owner-Earnings | 50.64 | |||||
| PEG Ratio | 0.52 | |||||
| PS Ratio | 0.39 | |||||
| PB Ratio | 1.64 | |||||
| Price-to-Tangible-Book | 2.54 | |||||
| Price-to-Free-Cash-Flow | 39.31 | |||||
| Price-to-Operating-Cash-Flow | 8.32 | |||||
| EV-to-EBIT | 10.28 | |||||
| EV-to-EBITDA | 6.04 | |||||
| EV-to-Revenue | 0.78 | |||||
| EV-to-FCF | 77.95 | |||||
| Price-to-GF-Value | 0.39 | |||||
| Price-to-Projected-FCF | 0.73 | |||||
| Price-to-Median-PS-Value | 0.32 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.7 | |||||
| Price-to-Graham-Number | 1.41 | |||||
| Earnings Yield (Greenblatt) % | 9.74 | |||||
| FCF Yield % | 2.53 | |||||
| Forward Rate of Return (Yacktman) % | 29.55 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BenQ Medical Technology Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 4,767.352 | ||
| EPS (TTM) (NT$) | 2.35 | ||
| Beta | -0.64 | ||
| 3-Year Sharpe Ratio | 0.33 | ||
| 3-Year Sortino Ratio | 0.7 | ||
| Volatility % | 18.14 | ||
| 14-Day RSI | 40.91 | ||
| 14-Day ATR (NT$) | 1.690531 | ||
| 20-Day SMA (NT$) | 44.395 | ||
| 12-1 Month Momentum % | -17.57 | ||
| 52-Week Range (NT$) | 35 - 59.9 | ||
| Shares Outstanding (Mil) | 44.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BenQ Medical Technology Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BenQ Medical Technology Corp Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
BenQ Medical Technology Corp Frequently Asked Questions
What is BenQ Medical Technology Corp(ROCO:4116)'s stock price today?
The current price of ROCO:4116 is NT$41.35. The 52 week high of ROCO:4116 is NT$59.90 and 52 week low is NT$35.00.
When is next earnings date of BenQ Medical Technology Corp(ROCO:4116)?
The next earnings date of BenQ Medical Technology Corp(ROCO:4116) is .
Does BenQ Medical Technology Corp(ROCO:4116) pay dividends? If so, how much?
The Dividend Yield %  of BenQ Medical Technology Corp(ROCO:4116) is 5% (As of Today), Highest Dividend Payout Ratio of BenQ Medical Technology Corp(ROCO:4116) was 1.48. The lowest was 0.13. And the median was 0.81. The  Forward Dividend Yield % of BenQ Medical Technology Corp(ROCO:4116) is 5%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers